In environments characterized by hormone-resistant prostate cancer (25), research indicates that increased IL-4 levels substantially boost the clonogenic capacity of cancer stem cell-like entities (26) and augment the proliferation of androgen-sensitive LNCaP cells via IL-4 overexpression (27). Here, IL4 is linked to cancer.